170 related articles for article (PubMed ID: 22471454)
1. Effects of ABO and FUT2 genetic transcription absence on ABH histo-blood group antigen expression in lung cancer patients.
Li J; Li S; Liu Q; Li Y; Zhou Q; Yuan S; Wang Z
Asian Pac J Cancer Prev; 2011; 12(12):3201-6. PubMed ID: 22471454
[TBL] [Abstract][Full Text] [Related]
2. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
3. ABO, Secretor and Lewis histo-blood group systems influence the digestive form of Chagas disease.
Bernardo CR; Camargo AVS; Ronchi LS; de Oliveira AP; de Campos Júnior E; Borim AA; Brandão de Mattos CC; Bestetti RB; de Mattos LC
Infect Genet Evol; 2016 Nov; 45():170-175. PubMed ID: 27566333
[TBL] [Abstract][Full Text] [Related]
4. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
[TBL] [Abstract][Full Text] [Related]
5. FUT2 gene involved in expression of H blood group antigen on surface of human tumor cell lines BEL-7404, SGC-7901, and SPC-A-1.
Xing L; Guo LH
Acta Pharmacol Sin; 2000 Nov; 21(11):997-1001. PubMed ID: 11501068
[TBL] [Abstract][Full Text] [Related]
6. ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior.
Forni D; Cleynen I; Ferrante M; Cassinotti A; Cagliani R; Ardizzone S; Vermeire S; Fichera M; Lombardini M; Maconi G; de Franchis R; Asselta R; Biasin M; Clerici M; Sironi M
J Crohns Colitis; 2014 Jun; 8(6):489-94. PubMed ID: 24268527
[TBL] [Abstract][Full Text] [Related]
7. Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system.
Koda Y; Soejima M; Johnson PH; Smart E; Kimura H
Biochem Biophys Res Commun; 1997 Sep; 238(1):21-5. PubMed ID: 9299444
[TBL] [Abstract][Full Text] [Related]
8. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
Miyake M; Taki T; Hitomi S; Hakomori S
N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
[TBL] [Abstract][Full Text] [Related]
9. A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.
Liu L; Song X; Li X; Xue L; Ding S; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2713-2723. PubMed ID: 31552488
[TBL] [Abstract][Full Text] [Related]
10. ABO blood-group antigens in oral cancer.
Dabelsteen E; Gao S
J Dent Res; 2005 Jan; 84(1):21-8. PubMed ID: 15615870
[TBL] [Abstract][Full Text] [Related]
11. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
12. [Studies on distribution of H type 1-H type 4 antigens of ABO system and on FUT2 polymorphism].
Kimura H
Nihon Hoigaku Zasshi; 2000 Nov; 54(3):315-23. PubMed ID: 11218748
[TBL] [Abstract][Full Text] [Related]
13. Presence of H type 3/4 chains of ABO histo-blood group system in serous cells of human submandibular gland and regulation of their expression by the secretor gene (FUT2).
Liu Y; Fujitani N; Koda Y; Soejima M; Kimura H
J Histochem Cytochem; 1999 Jul; 47(7):889-94. PubMed ID: 10375377
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
16. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
17. Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.
Liu QX; Zheng H; Deng XF; Zhou D; Dai JG
World J Surg Oncol; 2015 Aug; 13():238. PubMed ID: 26245297
[TBL] [Abstract][Full Text] [Related]
18. Association between expression of the H histo-blood group antigen, alpha1,2fucosyltransferases polymorphism of wild rabbits, and sensitivity to rabbit hemorrhagic disease virus.
Guillon P; Ruvoën-Clouet N; Le Moullac-Vaidye B; Marchandeau S; Le Pendu J
Glycobiology; 2009 Jan; 19(1):21-8. PubMed ID: 18842963
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy.
Shin KC; Choi EY; Chung JH; Jeon C; Lee KH
Anticancer Res; 2012 Jan; 32(1):163-7. PubMed ID: 22213302
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
